PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Newborns require better care to improve survival and long-term health

2025-06-25
(Press-News.org) More effective platforms for drug and medical device development and better cross sector engagement are urgently required to prevent the ‘unacceptably high’ newborn death rate, according to a global report.

The Lancet Child & Adolescent Health Commission on the future of neonatology report found this field of medicine faced significant challenges across leadership, collaboration, regulation and funding, which were hindering better health outcomes for newborns.

The Lancet Commission was created to consider these challenges and design a roadmap to accelerate research and development that will improve health care for this vulnerable patient group.

The World Health Organization states 2.3 million children died in the first 28 days of life in 2022. About 6500 newborns die every day, amounting to 47 per cent of all child deaths under the age of five years.

Murdoch Children’s Research Institute (MCRI)’s Professor Peter Davis and Professor David Tingay, two of the commissioners, believed the cost of inaction would negatively influence future generations. 

Professor Davis, also from The Royal Women’s Hospital and the University of Melbourne, said when babies received the best start in life, it boosted the whole country’s productivity, resilience and future prosperity.

“Increased survival of newborns in their first month of life, especially those born extremely premature and those with life-threatening disease, reflects progress in perinatal and neonatal medicine in the past 25 years,” he said. However, newborn deaths remain unacceptably high globally with some of the most common health concerns affecting this group still very challenging to treat.

“The current platform for the development of drugs and medical devices to treat neonatal disorders is hindering outcomes, especially babies born preterm or needing critical care. Off-label or off-licence use of drugs with little evidence of effectiveness is very common, treatment remains largely based on a clinicians’ experience rather than evidence and more high-quality research to advance neonatology is required.”

The report, published in The Lancet Child & Adolescent Health, stated on a global scale neonatology was lagging behind other medical specialties in clinical advances that provide adequate preventive care, diagnostics and therapeutic interventions.

“There is a lack of innovation for both drugs and medical devices, excessive bureaucracy, discrepancies between authorities, a perception of research for newborn health as unimportant and a global shortage of neonatal expertise,” Professor Davis said. Meanwhile, there is a great need for better partnerships and engagement between neonatologists and specialists, allied health-care professionals, patients, families and advocacy groups. 

“These challenges demand the attention of ethics committees, regulatory bodies, health-care providers, industry, governments and the public.”

Publication: Daniele De Luca, Neena Modi, Peter Davis, Satoshi Kusuda, Saskia N De Wildt, Martin Keszler, Allyah Abbas-Hanif, Sandra E Juul, Mark Turner, J Jane Pillow, Nikki Robertson, Manuel Sanchez-Luna, David G Tingay, Alexandra Benachi, Flavia Bustreo, Gianluca Ianiro, Mark Hanson, Jan Deprest, Paolo De Coppi, Agnes van den Hoogen, William Tarnow-Mordi, Anna Zanin, Ju-Lee Oei, Huayan Zhang, Victor Javier Lara-Diaz, Lloyd Tooke, Heidi Flori, Walter Ricciardi and Steven H Abman. ‘The Lancet Child & Adolescent Health Commission on the future of neonatology,’ The Lancet Child & Adolescent Health. DOI: 10.1016/ S2352-4642(25)00106-3

*The content of this communication is the sole responsibility of MCRI and does not reflect the views of the NHMRC.

Funding:

Professor David Tingay received grants from the National Health and Medical Research Council, the Victorian Government, received consulting fees or honoraria for lectures from Getinge, Fischer & Paykel, and Chiesi Farmaceutici, is a member of the DSMB for a trial managed by Getinge and received research materials or assistance from Sentec and SLE. Professor Peter Davis receives funding from the National Health and Medical Research Council.

END


ELSE PRESS RELEASES FROM THIS DATE:

EMBARGOED: New study shows almost half of hospital patients in Malawi and Tanzania have multiple health conditions

2025-06-25
The Multilink Consortium, a NIHR-funded partnership between the Liverpool School of Tropical Medicine, the Malawi-Liverpool-Wellcome Programme, Muhimbili University of Health and Allied Sciences and Kilimanjaro Christian Medical University College, has published the first-of-its-kind research in sub-Saharan Africa to examine the scale and impact of ‘multimorbidity’ in patients admitted acutely to hospital. Multimorbidity refers to the presence of two or more chronic diseases. Researchers discovered that of 1007 ...

People with symptoms of chronic lung disease in Kenya face ‘catastrophic’ health costs

2025-06-25
A quarter of people seeking care for symptoms of chronic respiratory diseases in Kenya may incur ‘catastrophic’ health costs, new research published in The Lancet Global Health has found. A study of almost 300 adults accessing treatment for respiratory symptoms across five health facilities in Meru County, Kenya, found that over a quarter (26%) had ‘catastrophic health expenditure’ (CHE, defined as over 10% of their household’s monthly outgoings) relating to their illness and seeking care. The severe economic burden included ...

Sylvester Cancer Tip Sheet - June 2025

2025-06-25
JUNE 2025 TIP SHEET Alcohol & Cancer Sobering Truth: Alcohol-Fueled Cancer Deaths Rising Across U.S. (Video Available) Sylvester researchers have become the first to look at trends in alcohol-linked cancer mortality across the U.S. Their findings, presented last month at ASCO 2025, found that alcohol-related cancer deaths nationwide nearly doubled between 1990 and 2021. Moreover, the highest burden fell on men over 55, whose alcohol-linked cancer mortality rose by more than 1% a year between 2007 and 2021. “That’s a big and concerning rise,” said Chinmay Jani, M.D., Sylvester hematology and oncology ...

UC Davis and Proteus Space to launch first-ever dynamic digital twin into space

2025-06-25
The Center for Space Exploration Research at the University of California, Davis, has partnered with Proteus Space to launch a US government-sponsored satellite into space with a custom AI-enabled payload in a brand-new, first-ever rapid design-to-deployment small satellite. The team will launch the satellite and payload in October 2025 from Vanderberg, CA. From the time the project was fully approved, the design and launch will occur within an unprecedented 13 months. (The normal pace for small satellites is often measured in years.) The UC Davis-designed ...

Olympians' hearts in focus: groundbreaking study reveals elite rowers' surprising AFib risk

2025-06-25
SYDNEY, Australia - A new study involving 121 former elite rowers from Australia has revealed one in five develops atrial fibrillation (AFib). This common heart rhythm condition can lead to stroke and heart failure in some individuals, but the researchers identified new genetic and clinical tools that enable early preventive strategies.   Researchers also found the retired rowers, who include former Olympians, are almost seven times more likely to develop AFib than the general population – despite having far fewer AFib risk factors like high ...

Common medicine for autoimmune diseases works on giant cell arteritis

2025-06-25
A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a team at the Perelman School of Medicine at the University of Pennsylvania published in the New England Journal of Medicine. Causing the body’s immune system to attack blood vessels in the head, neck, and other areas, giant cell arteritis often leads to headaches, vision loss, and even aortic aneurysms. But nearly half of patients taking upadacitinib in a new Phase 3 clinical trial achieved sustained remission— while reducing their dependence on glucocorticoids (typically called “steroids”), ...

Your neighborhood may be tied to risk of inflammation, dementia biomarkers

2025-06-25
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, JUNE 25, 2025   MINNEAPOLIS — People living in more disadvantaged neighborhoods may be more likely to have biomarkers for inflammation and Alzheimer’s disease, according to a study published June 25, 2025, in Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that neighborhood factors cause these biomarkers: it only shows an association. “Studies have shown that living in less advantaged neighborhoods may increase your risk for Alzheimer’s ...

AAN issues position statement on possible therapies for neurological conditions

2025-06-25
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, JUNE 25, 2025 MINNEAPOLIS — The American Academy of Neurology (AAN) has issued a position statement on therapies for neurological conditions that have limited evidence or no approved use by the Food and Drug Administration (FDA). The statement is published June 25, 2025, in Neurology®, the medical journal of the American Academy of Neurology. The statement includes guiding principles for discussions with patients and policymakers about these therapies. Although the statement includes illustrative examples, it does not provide clinical recommendations ...

Liver organoid breakthrough: Generating organ-specific blood vessels

2025-06-25
CINCINNATI – Scientists from Cincinnati Children’s and colleagues based in Japan report achieving a major step forward in organoid technology--producing liver tissue that grows its own internal blood vessels. This significant advance could lead to new ways to help people living with hemophilia and other coagulation disorders while also taking another step closer to producing transplantable repair tissues for people with damaged livers. The study, led by Takanori Takebe, MD, PhD, director ...

LRA awards 2025 Lupus Insight Prize to Dr. Deepak Rao for uncovering key drivers of immune imbalance in lupus

2025-06-25
BOSTON, MA – June 25, 2025 – The Lupus Research Alliance (LRA) proudly awarded the 2025 Lupus Insight Prize today to highly respected immunologist Deepak Rao, MD, PhD, Brigham and Women’s Hospital and Harvard Medical School. The Prize recognizes Dr. Rao’s pioneering and widely reported findings published in Nature, which reveal a previously unknown imbalance in key immune cells that contribute to lupus. The study sheds light on how this imbalance arises and identifies a potential target for restoring immune system regulation in people with the disease. Dr. Rao was honored today at the Federation of Clinical Immunology Societies (FOCIS) 2025 meeting in ...

LAST 30 PRESS RELEASES:

Global analysis shows hidden damage from men’s alcohol use

DRI recognizes Ashley Cornish as the 2025 Peter B. Wagner Memorial Award Winner for Women in Atmospheric Sciences

Unlocking the blueprint for a powerful plant-based drug

Bringing modern science to vitamin biology: Isha Jain wins NIH Transformative Research Award

University of Houston scientists learn that rare bacterium ‘plays dead’ to survive

Introduced animals change how island plants spread, new global study finds

Mayo Clinic researchers discover ‘traffic controller’ protein that protects DNA, and may help kill cancer cells

Protein sidekick exhibits dual roles in stress granule assembly and disassembly

New hope for MS

Kennesaw State professor receives grant to study cancer origins

Pain and antidepressant drug combo linked to increased seizure risk in older adults

Cancer researchers shape new strategies for immunotherapy

Physical exercise can ‘train’ the immune system

Calm red brocket deer can learn to "Come" and other commands - but the flightiest, most restless individuals struggle

China, the world's largest tea producer, is predicted to experience increases in land suitable for tea-growing under climate change, with the overall range shifting northwards, per AI modeling study

Composing crews for Mars missions

Early humans butchered elephants using small tools and made big tools from their bones

1,000-year-old gut microbiome revealed for young man who lived in pre-Hispanic Mexico

Bears and pandas in captivity develop significantly different gut microbiomes compared to their wild counterparts, and giant pandas in particular have less diverse microbiomes than their wild counterp

Prenatal and postnatal support apps might not work

Dancing dust devils trace raging winds on Mars

Raging winds on Mars

Real-time biopsies uncover hidden response to glioblastoma therapy

Repeated brain tumor sampling uncovers treatment response in patients with glioblastoma

Novel immunotherapy combination destroys colorectal liver metastases

Farmed totoaba could curb poaching

Avalanches: user-carried safety device increases survival time fivefold

It’s all in your head: Select neurons in the brainstem may hold the key to treating chronic pain

Time-restricted eating can boost athletes' health and performance

Burning issue: study finds fire a friend to some bees, a foe to others

[Press-News.org] Newborns require better care to improve survival and long-term health